The Section develops biotechnology industry policy on environmental and industrial biotechnology issues, promotes the use of industrial enzymes, conversion of biomass to energy and chemicals and innovative clean up technologies. The Section works closely with the U.S. Congress, federal agencies, and international organizations. The Section is active in promoting technologies that promote sustainable development. The Section also is involved with legislative and regulatory issues related to the use of industrial enzymes in manufacturing processes and with environmental biotechnology products used for environmental remediation. Principal federal regulatory agencies: DOE, EPA and USDA.
Staff Contact: Brent Erickson
|
|
Chairman
Alan Shaw, PhD
President & CEO
Codexis, Inc
|
Vice Chairman
Tjerk de Ruiter
Chief Executive Officer
Genencor® A Danisco Division
|
Member
William Baum
Executive VP, Business Development
Verenium Corporation
|
Member
Peter Boynton
Senior Vice President, Fermentation and Biomaterials
Tate & Lyle
|
Member
Charles Eggert
CEO
OPX Biotechnologies, Inc.
|
Member
Susan A. Ellerbusch
President
BP Biofuels North America, LLC
|
Member
Richard P. Eno
President & CEO
Metabolix, Inc
|
Member
Carolyn J. Fritz
President & CEO
Allylix, Inc
|
Member
Stephen J Gatto
Chief Executive Officer
Myriant
|
Member
Patrick R. Gruber, PhD, MBA
Chief Executive Officer
Gevo Incorporated
|
Member
Neal Gutterson, PhD
President & CEO
Mendel Biotechnology, Inc
|
Member
Bob Hartmayer
President & CEO
DSM, NV
|
Member
Jack Huttner
Executive Vice President of Corporate Development & Public Affairs
Gevo Incorporated
|
Member
Adam Monroe
President, Novozymes North America
Novozymes
|
Member
John P. Ranieri, PhD
Vice President and General Manager, DuPont Applied BioSciences - BioMaterials
DuPont Corporation
|
Member
Gerson Santos
Director, R&D Corporate
Abengoa Bioenergy New Technologies, Inc
|
Member
Joseph R. Skurla
President & CEO
Dupont Danisco Cellulosic Ethanol (DDCE)
|
Member
James R. Stoppert
President & CEO
Segetis, Inc
|
Member
Steven Tuttle
Global Business Director Biosciences Ventures & Business Development
The Dow Chemical Company
|
Member
Marc Verbruggen, PhD
President and Chief Executive Officer
NatureWorks, LLC
|
Member
Roger Wyse
Managing Director
Burrill & Company
|
Printer Friendly